138 related articles for article (PubMed ID: 30785994)
1. Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer.
Wang Q; Sun B; Meng X; Liu C; Cong Y; Wu S
J Radiat Res; 2019 May; 60(3):394-400. PubMed ID: 30785994
[TBL] [Abstract][Full Text] [Related]
2. Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis.
Foerster R; Eisele C; Bruckner T; Bostel T; Schlampp I; Wolf R; Debus J; Rief H
Radiat Oncol; 2015 Mar; 10():62. PubMed ID: 25884703
[TBL] [Abstract][Full Text] [Related]
3. Remineralization of lytic spinal metastases after radiotherapy.
Pielkenrood BJ; Visser TF; van Tol FR; Foppen W; Eppinga WSC; Verhoeff JJC; Bol GH; Van der Velden JM; Verlaan JJ
Spine J; 2023 Apr; 23(4):571-578. PubMed ID: 36623735
[TBL] [Abstract][Full Text] [Related]
4. Survival and Stability of Patients with Urothelial Cancer and Spinal Bone Metastases after Palliative Radiotherapy.
Foerster R; Hees K; Bruckner T; Bostel T; Schlampp I; Sprave T; Nicolay NH; Debus J; Rief H
Radiol Oncol; 2018 Jun; 52(2):189-194. PubMed ID: 30018523
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density loss in thoracic and lumbar vertebrae following radiation for abdominal cancers.
Wei RL; Jung BC; Manzano W; Sehgal V; Klempner SJ; Lee SP; Ramsinghani NS; Lall C
Radiother Oncol; 2016 Mar; 118(3):430-6. PubMed ID: 26993414
[TBL] [Abstract][Full Text] [Related]
6. Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patients.
Shapiro CL; Keating J; Angell JE; Janicek M; Gelman R; Hayes D; LeBoff MS
Cancer Invest; 1999; 17(8):566-74. PubMed ID: 10592763
[TBL] [Abstract][Full Text] [Related]
7. Association of Quality and Quantity of Bone Metastases and Computed Tomography Volumetric Bone Mineral Density With Prevalence of Vertebral Fractures in Breast Cancer Patients.
Neuhaus V; Abdullayev N; Hellmich M; Krämer S; Maintz D; Krug B; Borggrefe J
Clin Breast Cancer; 2016 Oct; 16(5):402-409. PubMed ID: 27346706
[TBL] [Abstract][Full Text] [Related]
8. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
Enright K; Clemons M; Chow E
Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
[TBL] [Abstract][Full Text] [Related]
9. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.
Zhao F; Ding G; Huang W; Li M; Fu Z; Yang G; Kong L; Zhang Y; Yu J
Clin Lung Cancer; 2015 Nov; 16(6):e111-9. PubMed ID: 25736696
[TBL] [Abstract][Full Text] [Related]
11. Differentiating intrapulmonary metastases from different primary tumors via quantitative dual-energy CT based iodine concentration and conventional CT attenuation.
Deniffel D; Sauter A; Dangelmaier J; Fingerle A; Rummeny EJ; Pfeiffer D
Eur J Radiol; 2019 Feb; 111():6-13. PubMed ID: 30691666
[TBL] [Abstract][Full Text] [Related]
12. Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?
Vassiliou V; Kalogeropoulou C; Petsas T; Leotsinidis M; Kardamakis D
Clin Exp Metastasis; 2007; 24(1):49-56. PubMed ID: 17295093
[TBL] [Abstract][Full Text] [Related]
13. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.
Aktas B; Kasimir-Bauer S; Lehmann N; Kimmig R; Tewes M
Oncol Rep; 2013 Jul; 30(1):441-7. PubMed ID: 23604361
[TBL] [Abstract][Full Text] [Related]
14. A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases.
Janssen S; Haus R; Schild SE; Rades D
Anticancer Res; 2020 Jan; 40(1):367-371. PubMed ID: 31892588
[TBL] [Abstract][Full Text] [Related]
15. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy--a feasibility study.
Chow E; Holden L; Rubenstein J; Christakis M; Sixel K; Vidmar M; Finkelstein J; Hayter C; Loblaw A; Wong R; Szumacher E; Danjoux C
Radiother Oncol; 2004 Mar; 70(3):291-4. PubMed ID: 15064015
[TBL] [Abstract][Full Text] [Related]
17. Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
Radiat Oncol; 2018 Oct; 13(1):212. PubMed ID: 30376859
[TBL] [Abstract][Full Text] [Related]
18. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
[TBL] [Abstract][Full Text] [Related]
19. Determination of bone density in patients with sacral fractures via CT scan.
Berger-Groch J; Thiesen DM; Ntalos D; Grossterlinden LG; Hesse E; Fensky F; Hartel MJ
Orthop Traumatol Surg Res; 2018 Nov; 104(7):1037-1041. PubMed ID: 30243677
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
